Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: Different levels of viral integration are correlated with lesion grade

Gynecologic Oncology

Volumn 92, Issue 3, 2004, Pages 873-880

  Hudelist, Gernot ^a,b   Manavi, Mahmood ^a   Pischinger, Kerstin I D ^a   Watkins Riedel, Thomas ^a   Singer, Christian F ^a   Kubista, E ^a   Czerwenka, Klaus F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LKH Villach ^*  (Austria)

Author keywords

2D; Gel electrophoresis; HPV DNA; Physical state; Uterine cervix

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER RISK; CELL TRANSFORMATION; CONTROLLED STUDY; CYTODIAGNOSIS; DNA TRANSCRIPTION; FEMALE; GEL ELECTROPHORESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX EPITHELIUM; VIRUS DNA CELL DNA INTERACTION; WART VIRUS;

EID: 1342300675     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.035     Document Type: Article

References (28)

1. zur Hausen H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin. Cancer Biol. 9:1999;405-411.
2. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J.et al. Prevalence of the human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:1995;796-802.
3. Schiffman M.H., Bauer H.M., Hoover R.N., Glass A.G., Cadell D.M., Rush B.B.et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:1993;958-964.
4. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
5. Cripe T.P., Haugen T.H., Turk J.P., Tabatabai F., Schmid P.G. III, Durst M.et al. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J. 6:1987;3745-3753.
6. Jeon S., Lambert P.F. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 92:1995;1654-1658.
7. Park T.W., Fujiwara H., Wright T.C. Molecular biology of cervical cancer and its precursors. Cancer. 76:1995;1902-1913.
8. Van Ranst M., Kaplan J.B., Burk R.D. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J. Gen. Virol. 73:1992;2653-2660.
9. Venuti A., Marcante M.L. Presence of human papillomavirus type 18 DNA in vulvar carcinomas and its integration into the cell genome. J. Gen. Virol. 70:1989;1587-1592.
10. Jeon S., Allen-Hoffmann B.L., Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:1995;2989-2997.
11. Cullen A.P., Reid R., Campion M., Lorincz A.T. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J. Virol. 65:1991;606-612.
12. Pirami L., Giache V., Becciolini A. Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J. Clin. Pathol. 50:1997;600-604.
13. Park J.S., Hwang E.S., Park S.N., Ahn H.K., Um S.J., Kim C.J.et al. Physical status and expression of HPV genes in cervical cancers. Gynecol. Oncol. 65:1997;121-129.
14. Matsukura T., Koi S., Sugase M. Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology. 172:1989;63-72.
15. Fuchs P.G., Girardi F., Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int. J. Cancer. 43:1989;41-44.
16. Das B.C., Sharma J.K., Gopalakrishna V., Luthra U.K. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. Gen. Virol. 73:1992;2327-2336.
17. Lorincz A.T. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J. Obstet. Gynaecol. Res. 22:1996;629-636.
18. Cope J.U., Hildesheim A., Schiffman M.H., Manos M.M., Lorincz A.T., Burk R.D.et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J. Clin. Microbiol. 35:1997;2262-2265.
19. Venuti A., Manni V., Morello R., De Marco F., Marzetti F., Marcante M.L. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J. Med. Virol. 60:2000;396-402.
20. Peitsaro P., Johansson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40:2002;886-891.
21. Nasiell K., Roger V., Nasiell M. Behaviour of mild cervical dysplasia during long-term follow-up. Obstet. Gynecol. 67:1986;665-669.
22. Koutsky L.A., Holmes K.K., Critchlow C.W., Stevens C.E., Paavonen J., Beckmann A.M.et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327:1992;1272-1278.
23. Munoz M., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V.et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:2003;518-527.
24. Sotlar K., Selinka H.C., Menton M., Kandolf R., Bültmann B. Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol. Oncol. 69:1998;114-121.
25. Cornelissen M.T., Smits H.L., Briet M.A., van den Tweel J.G., Struyk A.P., van der Noordaa J.et al. Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J. Gen. Virol. 71:1990;1243-1246.
26. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R.et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1999;1030-1034.
27. Badaracco G., Venuti A., Sedati A., Marcante M.L. HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J. Med. Virol. 67:2002;574-582.
28. Vernon S.D., Unger E.R., Miller D.L., Lee D.R., Reeves W.C. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int. J. Cancer. 74:1997;50-56.